Aktis Oncology, Inc. Share Price
NASDAQ: AKTSAktis Oncology, Inc. Stock Performance
Aktis Oncology, Inc. Share Price Today
As of 31 October 2026, Aktis Oncology, Inc.'s share price is $15.94. The stock opened at $16.79, compared to its previous close of $16.83. During today's trading session, Aktis Oncology, Inc.'s share price traded between $15.82 and $16.79, with an average price of $16.30. Over the past 52 weeks, the stock has recorded a high of $34.06 and a low of $14.72. In terms of performance, Aktis Oncology, Inc.'s share price has declined by 14.99% over the last six months and is down 20.91% on a year-on-year basis.
Aktis Oncology, Inc. Share Price Chart
Aktis Oncology, Inc. Quarterly Profit & Loss
All figures in USD
Aktis Oncology, Inc. Annual Profit & Loss
All figures in USD
About Aktis Oncology, Inc.
Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.
Aktis Oncology, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $18.91 | $15.97 | -18.02% |
Sep 2026 | $26.02 | $19.48 | -25.68% |
Aug 2026 | $21.68 | $26.21 | +18.81% |
Jul 2026 | $31.66 | $22.06 | -31.72% |
Jun 2026 | $20.24 | $32.31 | +55.67% |
May 2026 | $18.50 | $20.75 | +10.69% |
Apr 2026 | $18.54 | $18.75 | +4.57% |
Mar 2026 | $19.57 | $17.93 | -11.26% |
Feb 2026 | $20.00 | $20.20 | +0.25% |
Jan 2026 | $27.43 | $20.16 | N/A |